How to Buy Delcath Systems Stock
Delcath Systems Inc
Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers.
Delcath Systems stock last closed at $12.22, down 1.69% from the previous day, and has increased 7.19% in one year. It has overperformed other stocks in the Medical Devices industry by 1.07 percentage points. Delcath Systems stock is currently +50.49% from its 52-week low of $8.12, and -11.06% from its 52-week high of $13.74.
As of Jul 24, 2026, there are 34.52M shares of DCTH outstanding. The market cap of DCTH is $421.85M. In the past 24 hours, 299,000 DCTH shares were traded.
How to Buy Delcath Systems Stock
Not sure how to invest in Delcath Systems stock? Here's how.
- Figure out where to buy Delcath Systems stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Delcath Systems stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Select your method of payment and add your information.
- Analyze Delcath Systems stock: The Delcath Systems ticker symbol is DCTH. Is Delcath Systems stock a good investment? Should you buy shares of DCTH? How do DCTH's underlying business fundamentals look? Do top analysts think Delcath Systems is a good buy? Why has DCTH's stock price moved recently? (Hint: Our stock analysis website can help you understand if DCTH is a good stock to buy).
- Make your DCTH buy order: Decide if you will purchase DCTH shares at the current market price or use a limit order to purchase DCTH shares at a given price.
- Get the latest scoop on your investment in DCTH: Create a watchlist to monitor your position in Delcath Systems stock.
Step 1: Figure out where to buy Delcath Systems stock
You will need an online brokerage account in order to access the NASDAQ market and buy DCTH stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Technology to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected your brokerage, it's time to fill out some personal information so you can buy DCTH today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create your new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on our top ranked stock market app, you need to deposit funds:
Check out the video below for more details depositing funds into your brokerage account.
Step 4: Analyze Delcath Systems stock
After you have selected the best place to buy Delcath Systems stock, it's very important to research their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
Delcath Systems quick stats
DCTH Overview
WallStreetZen was created to help average investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on DCTH's stock page.
Is DCTH stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge DCTH's true value.
Using relative valuations metrics:
- DCTH may be overvalued based on its P/E ratio of 611x, relative to Medical Devices industry P/E ratio of 21.47x
- DCTH could be overvalued based on its P/B ratio of 3.74x, relative to Medical Devices industry P/B ratio of 3.11x
You can do additional valuation analysis on DCTH's stock here.
DCTH Financial Summary
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the DCTH balance sheet.
- Total DCTH debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the DCTH balance sheet.
- DCTH's operating cash flow of $21.17M allows it to safely service it's debt of $907.00k.
- DCTH profit margin has gone up from -26.4% to 0.6% in the past year.
- DCTH has a low debt to equity ratio of 0.11.
Negative Health Checks:
- DCTH earnings of $1.96M is not enough to cover its interest payments.
Do analysts think it's a good time to buy DCTH stock
Out of 1 Equities analysts who research DCTH, the consensus analyst rating on Delcath Systems is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Delcath Systems stock forecast page.
DCTH Technicals
DCTH Earnings
Last year, DCTH revenue was $90.44M. In the last 5 year, DCTH's revenue has increased by 120.38% per year. This was faster than the Medical Devices industry average of 9.86%.
Dig into DCTH's earnings and revenue performance here.
What are DCTH executives and large shareholders up to?
In the last 12 months, executives and large shareholders at DCTH have bought more shares than they have sold.
Sandra Pennell, Chief Financial Officer of DCTH, was the latest DCTH insider to buy. They bought $50,018.32 worth of DCTH stock on Mar 6, 2026.
Learn more about who owns DCTH stock here.
Does DCTH provide a stable income stream?
No, Delcath Systems doesn't provide an income stream by paying out dividends.
What others are saying about DCTH
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your DCTH buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific dollar amount limit, use a limit order.
Press the Open Trade button and your broker will execute the order.
If you need additional assistance investing in stocks on eToro, click the how to video below:
Step 6: Get the latest scoop on your investment in DCTH
Now that you own some DCTH stock, you'll want to keep up with your new investment.
Start a watchlist to track the most important metrics related to your DCTH stock.
DCTH Feed
No news
There is no news on the companies in your watchlist or you don't have enough companies added to your list.
How to Buy Stock in Delcath Systems
To summarize, here are the 6 steps to buy stock in Delcath Systems:
- Figure out where to buy Delcath Systems stock
- Sign up for your brokerage account
- Fund your brokerage account
- Analyze Delcath Systems stock
- Make your DCTH buy order
- Get the latest scoop on your investment in DCTH
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your investment in Delcath Systems, click below.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.